ACETO Corp (ACET) Misses Q2 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
ACETO Reports Fiscal 2017 Second Quarter Results
February 2, 2017 5:05 PM ESTPORT WASHINGTON, N.Y., Feb. 02, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq: ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the second quarter of Fiscal 2017 ended December 31, 2016.
Second Quarter Fiscal 2017 versus Second Quarter Fiscal 2016
Net sales of $125.6 million versus $131.7 million, a 4.6% decreaseGross profit of $30.8 million versus $35.9 million, a 14.1% decreaseNet loss of $0.6 million versus net income... More


